Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

NCT00084214

Conditions
Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Univ Of Arkansas/Arkansas Research Center Little Rock, Arkansas, United States
  • Scripps Cancer Center San Diego, California, United States
  • Northern California Melanoma Center San Francisco, California, United States
View all 28 locations
View Trial Details
Completed

Epothilone B in Treating Patients With CNS Metastases From Breast Cancer

NCT00450866

Conditions
Brain Diseases, Brain Neoplasms, Breast Cancer, +18 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

NCT00083070

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Fairview University Medical Center - University Campus Minneapolis, Minnesota, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View all 16 locations
View Trial Details
Completed

Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer

NCT00463788

Conditions
Breast Diseases, Breast Neoplasm, Breast Neoplasms, +8 more
Locations
  • Research Site Campbelltown, New South Wales, Australia
  • Research Site Liverpool, New South Wales, Australia
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Malvern, Victoria, Australia
View all 46 locations
View Trial Details
Completed

A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice

NCT01460745

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Merck Serono Research Site Bristol, United Kingdom
  • Merck Serono Research Site Liverpool, United Kingdom
  • Merck Serono Research Site London, United Kingdom
  • Merck Serono Research Site Manchester, United Kingdom
View Trial Details
Completed

A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer

NCT00808418

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Pacific Coast Hematology/Oncology Medical Group Fountain Valley, California, United States
  • Mayo Clinic Rochester, Maryland, United States
  • Mid Dakota Clinic Bismarck, North Dakota, United States
  • University of Texas Health Science Center, Cancer Therapy & Research Center, Institute for Drug Development San Antonio, Texas, United States
View Trial Details

Related conditions